Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Inventory (2021 - 2024)

PAVmed has reported Inventory over the past 4 years, most recently at $687000.0 for Q2 2024.

  • Quarterly results put Inventory at $687000.0 for Q2 2024, changed N/A from a year ago — trailing twelve months through Jun 2024 was $687000.0 (changed N/A YoY), and the annual figure for FY2023 was $278000.0, up 150.45%.
  • Inventory for Q2 2024 was $687000.0 at PAVmed, up from $410000.0 in the prior quarter.
  • Over the last five years, Inventory for PAVM hit a ceiling of $687000.0 in Q2 2024 and a floor of $50000.0 in Q3 2021.
  • Median Inventory over the past 4 years was $278000.0 (2023), compared with a mean of $307200.0.
  • Peak annual rise in Inventory hit 150.45% in 2023, while the deepest fall reached 150.45% in 2023.
  • PAVmed's Inventory stood at $50000.0 in 2021, then skyrocketed by 122.0% to $111000.0 in 2022, then surged by 150.45% to $278000.0 in 2023, then skyrocketed by 147.12% to $687000.0 in 2024.
  • The last three reported values for Inventory were $687000.0 (Q2 2024), $410000.0 (Q1 2024), and $278000.0 (Q4 2023) per Business Quant data.